Literature DB >> 26810223

Ptpn22 Modifies Regulatory T Cell Homeostasis via GITR Upregulation.

Dominika J Nowakowska1, Stephan Kissler2.   

Abstract

PTPN22 gene variation associates with multiple autoimmune diseases, including type 1 diabetes and rheumatoid arthritis. Loss of function studies have demonstrated that PTPN22 impinges on the homeostatic behavior of regulatory T (Treg) cells, a lineage critical for immune tolerance. The frequency and absolute number of Treg cells is increased in Ptpn22-deficient mice, but the mechanism driving this increase is unknown. In this study, we show that Ptpn22 knockdown (KD) promoted the expansion of the Treg cell compartment by upregulating the glucocorticoid-induced TNFR family-related protein (GITR) and increasing GITR signaling. Ptpn22 KD did not accelerate cell division but instead prolonged Treg cell survival, as measured by a decrease in the frequency of apoptotic Treg cells. Loss of Ptpn22 caused a concomitant increase in the proportion of CD44(hi)CD62L(lo) effector Treg cells, at the expense of CD44(lo)CD62L(hi) central Treg cells. The increase in Treg cell numbers, but not their differentiation toward an effector phenotype, was dependent on GITR signaling, because blockade of GITR ligand prevented Treg cell expansion caused by Ptpn22 KD. These findings indicate that GITR plays a key role in regulating the overall size of the Treg cell pool. Our results suggest that the size and composition of the Treg cell compartment are independently controlled and have implications for the design of immunotherapies that seek to improve Treg cell function.
Copyright © 2016 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26810223      PMCID: PMC4761465          DOI: 10.4049/jimmunol.1501877

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  PTPN22 alters the development of regulatory T cells in the thymus.

Authors:  Christian J Maine; Emma E Hamilton-Williams; Jocelyn Cheung; Stephanie M Stanford; Nunzio Bottini; Linda S Wicker; Linda A Sherman
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

2.  Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling.

Authors:  Adrian F Arechiga; Tania Habib; Yantao He; Xian Zhang; Zhong-Yin Zhang; Andrew Funk; Jane H Buckner
Journal:  J Immunol       Date:  2009-03-15       Impact factor: 5.422

3.  Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients.

Authors:  Michelle Rosenzwajg; Guillaume Churlaud; Roberto Mallone; Adrien Six; Nicolas Dérian; Wahiba Chaara; Roberta Lorenzon; S Alice Long; Jane H Buckner; Georgia Afonso; Hang-Phuong Pham; Agnès Hartemann; Aixin Yu; Alberto Pugliese; Thomas R Malek; David Klatzmann
Journal:  J Autoimmun       Date:  2015-01-26       Impact factor: 7.094

4.  Altered B cell homeostasis is associated with type I diabetes and carriers of the PTPN22 allelic variant.

Authors:  Tania Habib; Andrew Funk; Mary Rieck; Archana Brahmandam; Xuezhi Dai; Anil K Panigrahi; Eline T Luning Prak; Almut Meyer-Bahlburg; Srinath Sanda; Carla Greenbaum; David J Rawlings; Jane H Buckner
Journal:  J Immunol       Date:  2011-11-21       Impact factor: 5.422

5.  Stimulation of CD25(+)CD4(+) regulatory T cells through GITR breaks immunological self-tolerance.

Authors:  Jun Shimizu; Sayuri Yamazaki; Takeshi Takahashi; Yasumasa Ishida; Shimon Sakaguchi
Journal:  Nat Immunol       Date:  2002-01-22       Impact factor: 25.606

6.  Engagement of glucocorticoid-induced TNFR family-related receptor on effector T cells by its ligand mediates resistance to suppression by CD4+CD25+ T cells.

Authors:  Geoffrey L Stephens; Rebecca S McHugh; Matthew J Whitters; Deborah A Young; Deborah Luxenberg; Beatriz M Carreno; Mary Collins; Ethan M Shevach
Journal:  J Immunol       Date:  2004-10-15       Impact factor: 5.422

7.  The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity.

Authors:  Yaya Wang; Iftach Shaked; Stephanie M Stanford; Wenbo Zhou; Julie M Curtsinger; Zbigniew Mikulski; Zachary R Shaheen; Genhong Cheng; Kristy Sawatzke; Amanda M Campbell; Jennifer L Auger; Hatice Bilgic; Fernanda M Shoyama; David O Schmeling; Henry H Balfour; Kiminori Hasegawa; Andrew C Chan; John A Corbett; Bryce A Binstadt; Matthew F Mescher; Klaus Ley; Nunzio Bottini; Erik J Peterson
Journal:  Immunity       Date:  2013-07-18       Impact factor: 31.745

8.  Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1/2 randomised, double-blind, placebo-controlled trial.

Authors:  Agnès Hartemann; Gilbert Bensimon; Christine A Payan; Sophie Jacqueminet; Olivier Bourron; Nathalie Nicolas; Michèle Fonfrede; Michelle Rosenzwajg; Claude Bernard; David Klatzmann
Journal:  Lancet Diabetes Endocrinol       Date:  2013-10-08       Impact factor: 32.069

9.  IL-2 reverses established type 1 diabetes in NOD mice by a local effect on pancreatic regulatory T cells.

Authors:  Yenkel Grinberg-Bleyer; Audrey Baeyens; Sylvaine You; Rima Elhage; Gwladys Fourcade; Sylvie Gregoire; Nicolas Cagnard; Wassila Carpentier; Qizhi Tang; Jeffrey Bluestone; Lucienne Chatenoud; David Klatzmann; Benoît L Salomon; Eliane Piaggio
Journal:  J Exp Med       Date:  2010-08-02       Impact factor: 14.307

10.  Glucocorticoid-Induced TNF Receptor Family-Related Protein Ligand is Requisite for Optimal Functioning of Regulatory CD4(+) T Cells.

Authors:  Gongxian Liao; Michael S O'Keeffe; Guoxing Wang; Boaz van Driel; Rene de Waal Malefyt; Hans-Christian Reinecker; Roland W Herzog; Cox Terhorst
Journal:  Front Immunol       Date:  2014-02-03       Impact factor: 7.561

View more
  9 in total

1.  CD151 Expression Is Associated with a Hyperproliferative T Cell Phenotype.

Authors:  Lillian Seu; Christopher Tidwell; Laura Timares; Alexandra Duverger; Frederic H Wagner; Paul A Goepfert; Andrew O Westfall; Steffanie Sabbaj; Olaf Kutsch
Journal:  J Immunol       Date:  2017-09-27       Impact factor: 5.422

Review 2.  Beyond TNF: TNF superfamily cytokines as targets for the treatment of rheumatic diseases.

Authors:  Michael Croft; Richard M Siegel
Journal:  Nat Rev Rheumatol       Date:  2017-03-09       Impact factor: 20.543

Review 3.  The life and death of immune cell types: the role of BCL-2 anti-apoptotic molecules.

Authors:  Emma M Carrington; David M Tarlinton; Daniel H Gray; Nicholas D Huntington; Yifan Zhan; Andrew M Lew
Journal:  Immunol Cell Biol       Date:  2017-09-06       Impact factor: 5.126

4.  Interleukin 4 promotes the development of ex-Foxp3 Th2 cells during immunity to intestinal helminths.

Authors:  Victoria S Pelly; Stephanie M Coomes; Yashaswini Kannan; Manolis Gialitakis; Lewis J Entwistle; Jimena Perez-Lloret; Stephanie Czieso; Isobel S Okoye; Dominik Rückerl; Judith E Allen; Frank Brombacher; Mark S Wilson
Journal:  J Exp Med       Date:  2017-05-15       Impact factor: 14.307

Review 5.  Mechanisms by Which B Cells and Regulatory T Cells Influence Development of Murine Organ-Specific Autoimmune Diseases.

Authors:  Jason S Ellis; Helen Braley-Mullen
Journal:  J Clin Med       Date:  2017-01-26       Impact factor: 4.241

6.  The Role of NOD Mice in Type 1 Diabetes Research: Lessons from the Past and Recommendations for the Future.

Authors:  Yi-Guang Chen; Clayton E Mathews; John P Driver
Journal:  Front Endocrinol (Lausanne)       Date:  2018-02-23       Impact factor: 5.555

Review 7.  The Role of GITR/GITRL Interaction in Autoimmune Diseases.

Authors:  Jie Tian; Beibei Zhang; Ke Rui; Shengjun Wang
Journal:  Front Immunol       Date:  2020-10-09       Impact factor: 7.561

Review 8.  Influence of PTPN22 Allotypes on Innate and Adaptive Immune Function in Health and Disease.

Authors:  Lucas H Armitage; Mark A Wallet; Clayton E Mathews
Journal:  Front Immunol       Date:  2021-02-25       Impact factor: 7.561

Review 9.  B cell-T cell interplay in immune regulation: A focus on follicular regulatory T and regulatory B cell functions.

Authors:  Diaoyi Tan; Wei Yin; Fei Guan; Wanjiang Zeng; Pamela Lee; Fabio Candotti; Louisa K James; Niels Olsen Saraiva Camara; S M Mansour Haeryfar; Yan Chen; Kamel Benlagha; Lewis Zhichang Shi; Jiahui Lei; Quan Gong; Zheng Liu; Chaohong Liu
Journal:  Front Cell Dev Biol       Date:  2022-09-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.